Cargando…

Pathophysiology and new targets for therapeutic options in Chagas heart disease

Detalles Bibliográficos
Autor principal:	Ferreira, João Marcos B Barbosa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Instituto Oswaldo Cruz, Ministério da Saúde 2022
Materias:	Article Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9172886/ https://www.ncbi.nlm.nih.gov/pubmed/35674529 http://dx.doi.org/10.1590/0074-02760210172chgsa

Ejemplares similares

Chronic Heart Disease after Treatment of Oral Acute Chagas Disease
por: Antunes, Andrei Fornanciari, et al.
Publicado: (2016)

The challenge of risk assessment in the riddle of Chagas heart disease
por: Marin-Neto, José Antonio, et al.
Publicado: (2022)

Targeting gut microbiome, is it always a therapeutic option?
por: Rodríguez-Nogales, Alba, et al.
Publicado: (2020)

Stroke in Chagas disease: from pathophysiology to clinical practice
por: Lage, Thaís Aparecida Reis, et al.
Publicado: (2022)

Commentary: Stimulating new options for heart failure management
por: Ryan, Christopher T., et al.
Publicado: (2022)

Osteoporosis: Pathophysiology and therapeutic options
por: Föger-Samwald, Ursula, et al.
Publicado: (2020)

Is targeting circulating T blood cells a therapeutic option for vitiligo?
por: Matos, T.R.
Publicado: (2020)

Dysregulation of Autonomic Nervous System in Chagas’ Heart Disease Is Associated with Altered Adipocytokines Levels
por: Barbosa-Ferreira, João Marcos, et al.
Publicado: (2015)

Heart Rate Variability and Chagas Heart Disease
por: Almeida-Santos, Marcos Antonio, et al.
Publicado: (2015)

Chagas disease and its historicity
por: Gomes, Ana Carolina Vimieiro
Publicado: (2022)

The challenges for targeting Chagas disease for elimination as a public health problem
por: Werneck, Guilherme Loureiro
Publicado: (2022)

A safe, effective, and reliable vaccine against Chagas disease should be described!
por: Silva, João S
Publicado: (2022)

Osteogenesis imperfecta—pathophysiology and therapeutic options
por: Etich, Julia, et al.
Publicado: (2020)

Including unpublished surveys in reviews on Chagas disease in Mexico
por: Buekens, Pierre, et al.
Publicado: (2020)

Chagas Disease — An Underestimated Global Public Health Challenge
por: Liu, Qin, et al.
Publicado: (2020)

A note on the the discovery of Chagas' disease
por: de Avila-Pires, Fernando Dias
Publicado: (2022)

Chagas Disease Has Now Gone Global
por: Tanowitz, Herbert B., et al.
Publicado: (2011)

Inner ear symptoms and disease: Pathophysiological understanding and therapeutic options
por: Ciuman, Raphael R.
Publicado: (2013)

Hepatic Encephalopathy: An Update on the Pathophysiology and Therapeutic Options
por: Elwir, Saleh, et al.
Publicado: (2017)

Genetic understanding of vascular anomalies: better classification and risk‐stratification with targeted therapeutic options – a new horizon for vascular anomaly patients
por: van der Vleuten, C.J.M.
Publicado: (2022)

Sarcomere length in the beating heart: Synchronicity is optional
por: Helmes, Michiel, et al.
Publicado: (2022)

Luteolin as a therapeutic option for multiple sclerosis
por: Theoharides, Theoharis C
Publicado: (2009)

Chagas disease challenge - New techniques for diagnosis and treatment address to control in endemic areas
por: Marins, José Ricardo Pio
Publicado: (2022)

Squalene Synthase As a Target for Chagas Disease Therapeutics
por: Shang, Na, et al.
Publicado: (2014)

Cardiovascular Disease in Chronic Kidney Disease: Pathophysiological Insights and Therapeutic Options
por: Jankowski, Joachim, et al.
Publicado: (2021)

Chagas disease: an impediment in achieving the Millennium Development Goals in Latin America
por: Franco-Paredes, Carlos, et al.
Publicado: (2007)

New targets for new therapeutic approaches
por: François, Bruno
Publicado: (2014)

Peeking into the mysterious world of Trypanosoma cruzi and Chagas disease
por: Macedo, Andréa M, et al.
Publicado: (2022)

Trypanosoma cruzi and Chagas disease: diversity, progress and challenges
por: Miles, Michael A
Publicado: (2022)

How is global change affecting Chagas disease landscapes?
por: Gürtler, Ricardo E
Publicado: (2022)

Messages from the morgue to rheumatology: from Chagas disease to giant cell arteritis
por: Wollheim, Frank A
Publicado: (2013)

FLT3-IRAK dual targeting: an exciting new therapeutic option guided by adaptive activation of immune response pathways
por: Rabik, Cara A., et al.
Publicado: (2020)

Whole-Genome Cardiac DNA Methylation Fingerprint and Gene Expression Analysis Provide New Insights in the Pathogenesis of Chronic Chagas Disease Cardiomyopathy
por: Laugier, Laurie, et al.
Publicado: (2017)

Acute Respiratory Distress Syndrome: Pathophysiology and Therapeutic Options
por: Pierrakos, Charalampos, et al.
Publicado: (2012)

Insulin resistance in the brain: A new therapeutic target for Alzheimer's disease
por: Umegaki, Hiroyuki
Publicado: (2013)

Surveillance of seroepidemiology and morbidity of Chagas disease in the Negro River, Brazilian Amazon
por: Coura, José Rodrigues, et al.
Publicado: (2018)

Chagas disease among pregnant Latin American women in the United Kingdom: time for action
por: Fernandez Turienzo, Cristina, et al.
Publicado: (2017)

Safety Profile of Nifurtimox for Treatment of Chagas Disease in the United States
por: Forsyth, Colin J., et al.
Publicado: (2016)

Stronger control-surveillance systems for vector-borne Chagas disease
por: Gurgel-Gonçalves, Rodrigo
Publicado: (2023)

Cytokine Networks as Targets for Preventing and Controlling Chagas Heart Disease
por: Koh, Carolina Cattoni, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_643b82rfceahm03h0aodalmd2d